Targeting α-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors in epilepsy

Bibliography

• Marmiroli P, Cavaletti G. The glutamatergic neurotransmission in the central nervous system. Curr Med Chem 2012;19:1269-76
   Google Scholar
• Lau A, Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch 2010;460:525-42
   PubMed Web of Science ®Google Scholar
• De Sarro G, Gitto R, Russo E, et al. AMPA receptor antagonists as potential anticonvulsant drugs. Curr Top Med Chem 2005;5:31-42
   PubMed Web of Science ®Google Scholar
• Rogawski MA. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol Scand Suppl 2013;197:9-18
   Google Scholar
• Russo E, Gitto R, Citraro R, et al. New AMPA antagonists in epilepsy. Expert Opin Investig Drugs 2012;21:1371-89
   PubMed Web of Science ®Google Scholar
• Chang PK, Verbich D, McKinney RA. AMPA receptors as drug targets in neurological disease–advantages, caveats, and future outlook. Eur J Neurosci 2012;35:1908-16
   PubMed Web of Science ®Google Scholar
• Rogawski MA. Revisiting AMPA receptors as an antiepileptic drug target. Epilepsy Curr 2011;11:56-63
   PubMed Web of Science ®Google Scholar
• Lees GJ. Pharmacology of AMPA/kainate receptor ligands and their therapeutic potential in neurological and psychiatric disorders. Drugs 2000;59:33-78
   PubMed Web of Science ®Google Scholar
• Bogaert E, d'Ydewalle C, Van Den Bosch L. Amyotrophic lateral sclerosis and excitotoxicity: from pathological mechanism to therapeutic target. CNS Neurol Disord Drug Targets 2010;9:297-304
   PubMed Web of Science ®Google Scholar
• Meldrum BS, Rogawski MA. Molecular targets for antiepileptic drug development. Neurotherapeutics 2007;4:18-61
   PubMed Web of Science ®Google Scholar
• Citraro R, Russo E, Gratteri S, et al. Effects of non-competitive AMPA receptor antagonists injected into some brain areas of WAG/Rij rats, an animal model of generalized absence epilepsy. Neuropharmacology 2006;51:1058-67
   PubMed Web of Science ®Google Scholar
• Lee CY, Fu WM, Chen CC, et al. Lamotrigine inhibits postsynaptic AMPA receptor and glutamate release in the dentate gyrus. Epilepsia 2008;49:888-97
   PubMed Web of Science ®Google Scholar
• Russo E, Constanti A, Ferreri G, et al. Nifedipine affects the anticonvulsant activity of topiramate in various animal models of epilepsy. Neuropharmacology 2004;46:865-78
   PubMed Web of Science ®Google Scholar
• Traynelis SF, Wollmuth LP, McBain CJ, et al. Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 2010;62:405-96
   PubMed Web of Science ®Google Scholar
• Sierra-Paredes G, Sierra-Marcuno G. Extrasynaptic GABA and glutamate receptors in epilepsy. CNS Neurol Disord Drug Targets 2007;6:288-300
   Google Scholar
• Li ST, Ju JG. Functional roles of synaptic and extrasynaptic NMDA receptors in physiological and pathological neuronal activities. Curr Drug Targets 2012;13:207-21
   PubMed Web of Science ®Google Scholar
• Liu SQ, Cull-Candy SG. Synaptic activity at calcium-permeable AMPA receptors induces a switch in receptor subtype. Nature 2000;405:454-8
   PubMed Web of Science ®Google Scholar
• Lu W, Shi Y, Jackson AC, et al. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 2009;62:254-68
   PubMed Web of Science ®Google Scholar
• Kortenbruck G, Berger E, Speckmann EJ, Musshoff U. RNA editing at the Q/R site for the glutamate receptor subunits GLUR2, GLUR5, and GLUR6 in hippocampus and temporal cortex from epileptic patients. Neurobiol Dis 2001;8:459-68
   PubMed Web of Science ®Google Scholar
• Pellegrini-Giampietro DE, Gorter JA, Bennett MV, Zukin RS. The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders. Trends Neurosci 1997;20:464-70
   PubMed Web of Science ®Google Scholar
• Liu SJ, Savtchouk I. Ca(2+) permeable AMPA receptors switch allegiances: mechanisms and consequences. J Physiol 2012;590:13-20
   Google Scholar
• Bowie D. Redefining the classification of AMPA-selective ionotropic glutamate receptors. J Physiol 2012;590:49-61
   Google Scholar
• Derkach VA, Oh MC, Guire ES, Soderling TR. Regulatory mechanisms of AMPA receptors in synaptic plasticity. Nat Rev Neurosci 2007;8:101-13
   PubMed Web of Science ®Google Scholar
• Sobolevsky AI, Rosconi MP, Gouaux E. X-ray structure, symmetry and mechanism of an AMPA-subtype glutamate receptor. Nature 2009;462:745-56
   PubMed Web of Science ®Google Scholar
• Cheng J, Dong J, Cui Y, et al. Interacting partners of AMPA-type glutamate receptors. J Mol Neurosci 2012;48:441-7
   Google Scholar
• Tolle TR, Berthele A, Zieglgansberger W, et al. Flip and flop variants of AMPA receptors in the rat lumbar spinal cord. Eur J Neurosci 1995;7:1414-19
   Google Scholar
• Sommer B, Keinanen K, Verdoorn TA, et al. Flip and flop: a cell-specific functional switch in glutamate-operated channels of the CNS. Science 1990;249:1580-5
   PubMed Web of Science ®Google Scholar
• Jackson AC, Nicoll RA. Stargazing from a new vantage–TARP modulation of AMPA receptor pharmacology. J Physiol 2011;589:5909-10
   Google Scholar
• Kato AS, Gill MB, Yu H, et al. TARPs differentially decorate AMPA receptors to specify neuropharmacology. Trends Neurosci 2010;33:241-8
   Google Scholar
• Menuz K, Stroud RM, Nicoll RA, Hays FA. TARP auxiliary subunits switch AMPA receptor antagonists into partial agonists. Science 2007;318:815-17
   Web of Science ®Google Scholar
• Maclean DM, Bowie D. Transmembrane AMPA receptor regulatory protein regulation of competitive antagonism: a problem of interpretation. J Physiol 2011;589:5383-90
   Google Scholar
• Gill MB, Kato AS, Wang H, Bredt DS. AMPA receptor modulation by cornichon-2 dictated by transmembrane AMPA receptor regulatory protein isoform. Eur J Neurosci 2012;35:182-94
   Google Scholar
• Diaz E. Regulation of AMPA receptors by transmembrane accessory proteins. Eur J Neurosci 2010;32:261-8
   PubMed Web of Science ®Google Scholar
• Tomita S, Fukata M, Nicoll RA, Bredt DS. Dynamic interaction of stargazin-like TARPs with cycling AMPA receptors at synapses. Science 2004;303:1508-11
   PubMed Web of Science ®Google Scholar
• Porter BE, Cui XN, Brooks-Kayal AR. Status epilepticus differentially alters AMPA and kainate receptor subunit expression in mature and immature dentate granule neurons. Eur J Neurosci 2006;23:2857-63
   Google Scholar
• Condorelli DF, Belluardo N, Mudo G, et al. Changes in gene expression of AMPA-selective glutamate receptor subunits induced by status epilepticus in rat brain. Neurochem Int 1994;25:367-76
   Google Scholar
• Grooms SY, Opitz T, Bennett MV, Zukin RS. Status epilepticus decreases glutamate receptor 2 mRNA and protein expression in hippocampal pyramidal cells before neuronal death. Proc Natl Acad Sci USA 2000;97:3631-6
   PubMed Web of Science ®Google Scholar
• Hu Y, Jiang L, Chen H, Zhang X. Expression of AMPA receptor subunits in hippocampus after status convulsion. Childs Nerv Syst 2012;28:911-18
   PubMed Web of Science ®Google Scholar
• Sanchez RM, Koh S, Rio C, et al. Decreased glutamate receptor 2 expression and enhanced epileptogenesis in immature rat hippocampus after perinatal hypoxia-induced seizures. J Neurosci 2001;21:8154-63
   PubMed Web of Science ®Google Scholar
• Rakhade SN, Zhou C, Aujla PK, et al. Early alterations of AMPA receptors mediate synaptic potentiation induced by neonatal seizures. J Neurosci 2008;28:7979-90
   PubMed Web of Science ®Google Scholar
• Blumcke I, Beck H, Scheffler B, et al. Altered distribution of the alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subunit GluR2(4) and the N-methyl-D-aspartate receptor subunit NMDAR1 in the hippocampus of patients with temporal lobe epilepsy. Acta Neuropathol 1996;92:576-87
   Google Scholar
• Lopes MW, Soares FM, de Mello N, et al. Time-dependent modulation of AMPA receptor phosphorylation and mRNA expression of NMDA receptors and glial glutamate transporters in the rat hippocampus and cerebral cortex in a pilocarpine model of epilepsy. Exp Brain Res 2013;226:153-63
   PubMed Web of Science ®Google Scholar
• Rajasekaran K, Todorovic M, Kapur J. Calcium-permeable AMPA receptors are expressed in a rodent model of status epilepticus. Ann Neurol 2012;72:91-102
   PubMed Web of Science ®Google Scholar
• Russo I, Bonini D, Via LL, et al. AMPA receptor properties are modulated in the early stages following pilocarpine-induced status epilepticus. Neuromolecular Med 2013;15:324-38
   PubMed Web of Science ®Google Scholar
• Krestel HE, Shimshek DR, Jensen V, et al. A genetic switch for epilepsy in adult mice. J Neurosci 2004;24:10568-78
   PubMed Web of Science ®Google Scholar
• Vollmar W, Gloger J, Berger E, et al. RNA editing (R/G site) and flip-flop splicing of the AMPA receptor subunit GluR2 in nervous tissue of epilepsy patients. Neurobiol Dis 2004;15:371-9
   PubMed Web of Science ®Google Scholar
• Prince HC, Tzingounis AV, Levey AI, Conn PJ. Functional downregulation of GluR2 in piriform cortex of kindled animals. Synapse 2000;38:489-98
   PubMed Web of Science ®Google Scholar
• Ekonomou A, Smith AL, Angelatou F. Changes in AMPA receptor binding and subunit messenger RNA expression in hippocampus and cortex in the pentylenetetrazole-induced ‘kindling' model of epilepsy. Brain Res Mol Brain Res 2001;95:27-35
   PubMedGoogle Scholar
• Fritsch B, Stott JJ, Joelle Donofrio J, Rogawski MA. Treatment of early and late kainic acid-induced status epilepticus with the noncompetitive AMPA receptor antagonist GYKI 52466. Epilepsia 2010;51:108-17
   PubMed Web of Science ®Google Scholar
• Barad Z, Shevtsova O, Arbuthnott GW, Leitch B. Selective loss of AMPA receptors at corticothalamic synapses in the epileptic stargazer mouse. Neuroscience 2012;217:19-31
   Web of Science ®Google Scholar
• Kennard JT, Barmanray R, Sampurno S, et al. Stargazin and AMPA receptor membrane expression is increased in the somatosensory cortex of Genetic Absence Epilepsy Rats from Strasbourg. Neurobiol Dis 2011;42:48-54
   Google Scholar
• Beyer B, Deleuze C, Letts VA, et al. Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4. Hum Mol Genet 2008;17:1738-49
   Web of Science ®Google Scholar
• Mineff EM, Weinberg RJ. Differential synaptic distribution of AMPA receptor subunits in the ventral posterior and reticular thalamic nuclei of the rat. Neuroscience 2000;101:969-82
   Google Scholar
• Meeren HK, Pijn JP, Van Luijtelaar EL, et al. Cortical focus drives widespread corticothalamic networks during spontaneous absence seizures in rats. J Neurosci 2002;22:1480-95
   PubMed Web of Science ®Google Scholar
• Kamphuis W, Gorter JA, Wadman WJ, Lopes da Silva FH. Hippocampal kindling leads to different changes in paired-pulse depression of local evoked field potentials in CA1 area and in fascia dentata. Neurosci Lett 1992;141:101-5
   Google Scholar
• Pollard H, Heron A, Moreau J, et al. Alterations of the GluR-B AMPA receptor subunit flip/flop expression in kainate-induced epilepsy and ischemia. Neuroscience 1993;57:545-54
   PubMed Web of Science ®Google Scholar
• Rosa ML, Jefferys JG, Sanders MW, Pearson RC. Expression of mRNAs encoding flip isoforms of GluR1 and GluR2 glutamate receptors is increased in rat hippocampus in epilepsy induced by tetanus toxin. Epilepsy Res 1999;36:243-51
   Google Scholar
• Seifert G, Schroder W, Hinterkeuser S, et al. Changes in flip/flop splicing of astroglial AMPA receptors in human temporal lobe epilepsy. Epilepsia 2002;43(Suppl 5):162-7
   Google Scholar
• Fornai F, Busceti CL, Kondratyev A, Gale K. AMPA receptor desensitization as a determinant of vulnerability to focally evoked status epilepticus. Eur J Neurosci 2005;21:455-63
   Google Scholar
• Gitai DL, Martinelli HN, Valente V, et al. Increased expression of GluR2-flip in the hippocampus of the Wistar audiogenic rat strain after acute and kindled seizures. Hippocampus 2010;20:125-33
   PubMed Web of Science ®Google Scholar
• Mathern GW, Pretorius JK, Kornblum HI, et al. Human hippocampal AMPA and NMDA mRNA levels in temporal lobe epilepsy patients. Brain 1997;120(Pt 11):1937-59
   Google Scholar
• Graebenitz S, Kedo O, Speckmann EJ, et al. Interictal-like network activity and receptor expression in the epileptic human lateral amygdala. Brain 2011;134:2929-47
   PubMed Web of Science ®Google Scholar
• Palomero-Gallagher N, Schleicher A, Bidmon HJ, et al. Multireceptor analysis in human neocortex reveals complex alterations of receptor ligand binding in focal epilepsies. Epilepsia 2012;53:1987-97
   PubMed Web of Science ®Google Scholar
• Sprengel R, Higuchi M, Monyer H, Seeburg PH. Glutamate receptor channels: a possible link between RNA editing in the brain and epilepsy. Adv Neurol 1999;79:525-34
   Google Scholar
• Harms JE, Benveniste M, Maclean JK, et al. Functional analysis of a novel positive allosteric modulator of AMPA receptors derived from a structure-based drug design strategy. Neuropharmacology 2013;64:45-52
   Google Scholar
• De Sarro G, Ferreri G, Gareri P, et al. Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents. Pharmacol Biochem Behav 2003;74:595-602
   PubMed Web of Science ®Google Scholar
• Hanada T, Hashizume Y, Tokuhara N, et al. Perampanel: a novel, orally active, noncompetitive AMPA-receptor antagonist that reduces seizure activity in rodent models of epilepsy. Epilepsia 2011;52:1331-40
   PubMed Web of Science ®Google Scholar
• Hara H, Yamada N, Kodama M, et al. Effect of YM872, a selective and highly water-soluble AMPA receptor antagonist, in the rat kindling and rekindling model of epilepsy. Eur J Pharmacol 2006;531:59-65
   PubMed Web of Science ®Google Scholar
• Yamaguchi S, Donevan SD, Rogawski MA. Anticonvulsant activity of AMPA/kainate antagonists: comparison of GYKI 52466 and NBOX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res 1993;15:179-84
   PubMed Web of Science ®Google Scholar
• Kodama M, Yamada N, Sato K, et al. Effects of YM90K, a selective AMPA receptor antagonist, on amygdala-kindling and long-term hippocampal potentiation in the rat. Eur J Pharmacol 1999;374:11-19
   PubMed Web of Science ®Google Scholar
• Orain D, Ofner S, Koller M, et al. 6-Amino quinazolinedione sulfonamides as orally active competitive AMPA receptor antagonists. Bioorg Med Chem Lett 2012;22:996-9
   PubMed Web of Science ®Google Scholar
• Koller M, Lingenhoehl K, Schmutz M, et al. Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity. Bioorg Med Chem Lett 2011;21:3358-61
   PubMed Web of Science ®Google Scholar
• Pitkanen A, Mathiesen C, Ronn LC, et al. Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat. Epilepsy Res 2007;74:45-54
   PubMed Web of Science ®Google Scholar
• Mazarati AM, Wasterlain CG. N-methyl-D-asparate receptor antagonists abolish the maintenance phase of self-sustaining status epilepticus in rat. Neurosci Lett 1999;265:187-90
   PubMed Web of Science ®Google Scholar
• Langer M, Brandt C, Zellinger C, Loscher W. Therapeutic window of opportunity for the neuroprotective effect of valproate versus the competitive AMPA receptor antagonist NS1209 following status epilepticus in rats. Neuropharmacology 2011;61:1033-47
   PubMed Web of Science ®Google Scholar
• Nielsen EO, Varming T, Mathiesen C, et al. SPD 502: a water-soluble and in vivo long-lasting AMPA antagonist with neuroprotective activity. J Pharmacol Exp Ther 1999;289:1492-501
   PubMed Web of Science ®Google Scholar
• Weiczner R, Krisztin-Peva B, Mihaly A. Blockade of AMPA-receptors attenuates 4-aminopyridine seizures, decreases the activation of inhibitory neurons but is ineffective against seizure-related astrocytic swelling. Epilepsy Res 2008;78:22-32
   PubMed Web of Science ®Google Scholar
• Loscher W, Rundfeldt C, Honack D. Low doses of NMDA receptor antagonists synergistically increase the anticonvulsant effect of the AMPA receptor antagonist NBQX in the kindling model of epilepsy. Eur J Neurosci 1993;5:1545-50
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Borowicz KK, Kleinrok Z, et al. Influence of combined treatment with NMDA and non-NMDA receptor antagonists on electroconvulsions in mice. Eur J Pharmacol 1995;281:327-33
   PubMed Web of Science ®Google Scholar
• De Sarro G, Chimirri A, Meldrum BS. Group III mGlu receptor agonists potentiate the anticonvulsant effect of AMPA and NMDA receptor block. Eur J Pharmacol 2002;451:55-61
   PubMedGoogle Scholar
• Mignani S, Bohme GA, Birraux G, et al. 9-Carboxymethyl-5H,10H-imidazo[1,2-a]indeno[1,2-e]pyrazin-4-one-2-carbocylic acid (RPR117824): selective anticonvulsive and neuroprotective AMPA antagonist. Bioorg Med Chem 2002;10:1627-37
   PubMed Web of Science ®Google Scholar
• Ohno K, Tsutsumi R, Matsumoto N, et al. Functional characterization of YM928, a novel moncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist. J Pharmacol Exp Ther 2003;306:66-72
   Google Scholar
• Yamashita H, Ohno K, Amada Y, et al. Effect of YM928, a novel AMPA receptor antagonist, on seizures in EL mice and kainate-induced seizures in rats. Naunyn Schmiedebergs Arch Pharmacol 2004;370:99-105
   Google Scholar
• Tarnawa I, Vize ES. 2,3-benzodiazepine AMPA antagonists. Restor Neurol Neurosci 1998;13:41-57
   PubMed Web of Science ®Google Scholar
• De Sarro A, De Sarro G, Gitto R, et al. Synthesis and anticonvulsant activity of new 2,3-benzodiazepines as AMPA receptor antagonists. Farmaco 1999;54:178-87
   Google Scholar
• Jakus R, Graf M, Ando RD, et al. Effect of two noncompetitive AMPA receptor antagonists GYKI 52466 and GYKI 53405 on vigilance, behavior and spike-wave discharges in a genetic rat model of absence epilepsy. Brain Res 2004;1008:236-44
   PubMed Web of Science ®Google Scholar
• Gitto R, Barreca ML, De Luca L, et al. Discovery of a novel and highly potent noncompetitive AMPA receptor antagonist. J Med Chem 2003;46:197-200
   PubMed Web of Science ®Google Scholar
• Russo E, Citraro R, De Fazio S, et al. Enhancement of anti-absence effects of ethosuximide by low doses of a noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor antagonist in a genetic animal model of absence epilepsy. Epilepsy Behav 2008;13:295-9
   PubMed Web of Science ®Google Scholar
• Lodge D, Bond A, O'Neill MJ, et al. Stereoselective effects-of 2,3-benzodiazepines in vivo: electrophysiology and neuroprotection studies. Neuropharmacology 1996;35:1681-8
   PubMed Web of Science ®Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 2002;51:31-71
   PubMed Web of Science ®Google Scholar
• Czuczwar SJ, Swiader M, Kuzniar H, et al. LY 300164, a novel antagonist of AMPA/kainate receptors, potentiates the anticonvulsive activity of antiepileptic drugs. Eur J Pharmacol 1998;359:103-9
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Kleinrok Z, Czuczwar SJ. Effects of LY 300164, a selective non-competitive antagonist of AMPA/KA receptors, on the protective activity of diazepam and diphenylhydantoin in the kindling model of epilepsy in rats. Pol J Pharmacol 1999;51:103
   PubMedGoogle Scholar
• Swiader M, Kuzniar H, Kleinrok Z, Czuczwar SJ. Influence of LY 300164, an AMPA/kainate receptor antagonist upon the anticonvulsant action of antiepileptic drugs against aminophylline-induced seizures in mice. Pol J Pharmacol 2003;55:103-7
   PubMedGoogle Scholar
• Erdo F, Berzsenyi P, Andrasi F. The AMPA-antagonist talampanel is neuroprotective in rodent models of focal cerebral ischemia. Brain Res Bull 2005;66:43-9
   PubMed Web of Science ®Google Scholar
• Liu XH, Wang P, Barks JD. The non-competitive AMPA antagonist LY 300168 (GYKI 53655) attenuates AMPA-induced hippocampal injury in neonatal rodents. Neurosci Lett 1997;235:93-7
   PubMed Web of Science ®Google Scholar
• Erdo F, Berzsenyi P, Nemet L, Andrasi F. Talampanel improves the functional deficit after transient focal cerebral ischemia in rats. A 30-day follow up study. Brain Res Bull 2006;68:269-76
   PubMed Web of Science ®Google Scholar
• Weiser T, Brenner M, Palluk R, et al. BIIR 561 CL: a novel combined antagonist of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and voltage-dependent sodium channels with anticonvulsive and neuroprotective properties. J Pharmacol Exp Ther 1999;289:1343-9
   PubMed Web of Science ®Google Scholar
• Taylor CP, Meldrum BS. Na+ channels as targets for neuroprotective drugs. Trends Pharmacol Sci 1995;16:309-16
   PubMed Web of Science ®Google Scholar
• Stone TW, Addae JI. The pharmacological manipulation of glutamate receptors and neuroprotection. Eur J Pharmacol 2002;447:285-96
   PubMed Web of Science ®Google Scholar
• Weiser T, Iizuka M, Nishimura S, et al. Characterization of the anticonvulsant and neuroprotectant BIIR 561 CL in vitro: effects on native and recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. Naunyn Schmiedebergs Arch Pharmacol 2000;362:419-26
   PubMed Web of Science ®Google Scholar
• Wienrich M, Brenner M, Loscher W, et al. In vivo pharmacology of BIIR 561 CL, a novel combined antagonist of AMPA receptors and voltage-dependent Na(+) channels. Br J Pharmacol 2001;133:789-96
   PubMed Web of Science ®Google Scholar
• Feigin V. Irampanel boehringer ingelheim. Curr Opin Investig Drugs 2002;3:908-10
   PubMedGoogle Scholar
• Blackburn-Munro G, Bomholt SF, Erichsen HK. Behavioural effects of the novel AMPA/GluR5 selective receptor antagonist NS1209 after systemic administration in animal models of experimental pain. Neuropharmacology 2004;47:351-62
   PubMed Web of Science ®Google Scholar
• Bialer M, Johannessen SI, Kupferberg HJ, et al. Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII). Epilepsy Res 2007;73:1-52
   PubMed Web of Science ®Google Scholar
• McCracken E, Fowler JH, Dewar D, et al. Grey matter and white matter ischemic damage is reduced by the competitive AMPA receptor antagonist, SPD 502. J Cereb Blood Flow Metab 2002;22:1090-7
   PubMed Web of Science ®Google Scholar
• Kapus G, Kertesz S, Gigler G, et al. Comparison of the AMPA antagonist action of new 2,3-benzodiazepines in vitro and their neuroprotective effects in vivo. Pharm Res 2004;21:317-23
   PubMed Web of Science ®Google Scholar
• Gigler G, Moricz K, Agoston M, et al. Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models. Br J Pharmacol 2007;152:151-60
   PubMed Web of Science ®Google Scholar
• Gressens P, Spedding M, Gigler G, et al. The effects of AMPA receptor antagonists in models of stroke and neurodegeneration. Eur J Pharmacol 2005;519:58-67
   PubMed Web of Science ®Google Scholar
• Matucz E, Moricz K, Gigler G, et al. Therapeutic time window of neuroprotection by non-competitive AMPA antagonists in transient and permanent focal cerebral ischemia in rats. Brain Res 2006;1123:60-7
   PubMed Web of Science ®Google Scholar
• Vegh MG, Kovacs AD, Kovacs G, et al. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death. Neurochem Int 2007;50:555-63
   PubMed Web of Science ®Google Scholar
• Kovacs A, Szenasi G. Effects of dofetilide and EGIS-7229, an antiarrhythmic agent possessing class III, IV, and IB activities, on myocardial refractoriness in hyperkalemia, hypokalemia, and during beta-adrenergic activation in the rabbit papillary muscle in vitro. J Pharmacol Sci 2006;100:303-9
   PubMed Web of Science ®Google Scholar
• Kovacs AD, Saje A, Wong A, et al. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease. Neuropharmacology 2011;60:405-9
   PubMed Web of Science ®Google Scholar
• Hibi S, Ueno K, Nagato S, et al. Discovery of 2-(2-oxo-1-phenyl-5-pyridin-2-yl-1,2-dihydropyridin-3-yl)benzonitrile (perampanel): a novel, noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid (AMPA) receptor antagonist. J Med Chem 2012;55:10584-600
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Hanada T. Preclinical pharmacology of perampanel, a selective non-competitive AMPA receptor antagonist. Acta Neurol Scand Suppl 2013(197):19-24
   Google Scholar
• Ikoma M, Oikawa M, Gill MB, et al. Regioselective domino metathesis of 7-oxanorbornenes and its application to the synthesis of biologically active glutamate analogues. European J Org Chem 2008;2008:5215-20
   PubMedGoogle Scholar
• Oikawa M, Ikoma M, Sasaki M, et al. Regioselective domino metathesis of unsymmetrical 7-oxanorbornenes with electron-rich vinyl acetate toward biologically active glutamate analogues. European J Org Chem 2009;2009:5531-48
   PubMedGoogle Scholar
• Gill MB, Frausto S, Ikoma M, et al. A series of structurally novel heterotricyclic alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptor-selective antagonists. Br J Pharmacol 2010;160:1417-29
   PubMed Web of Science ®Google Scholar
• Sutula TP. Experimental models of temporal lobe epilepsy: new insights from the study of kindling and synaptic reorganization. Epilepsia 1990;31(Suppl 3):S45-54
   Google Scholar
• Durmuller N, Craggs M, Meldrum BS. The effect of the non-NMDA receptor antagonist GYKI 52466 and NBQX and the competitive NMDA receptor antagonist D-CPPene on the development of amygdala kindling and on amygdala-kindled seizures. Epilepsy Res 1994;17:167-74
   PubMed Web of Science ®Google Scholar
• Meldrum BS, Craggs MD, Durmuller N, et al. The effects of AMPA receptor antagonists on kindled seizures and on reflex epilepsy in rodents and primates. Epilepsy Res Suppl 1992;9:307-11
   PubMedGoogle Scholar
• Namba T, Morimoto K, Sato K, et al. Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res 1994;638:36-44
   PubMed Web of Science ®Google Scholar
• De Sarro G, Di Paola ED, Gareri P, et al. Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats. Eur J Pharmacol 1999;368:149-59
   Google Scholar
• Lukomskaya NY, Lavrent'eva VV, Starshinova LA, et al. Effects of ionotropic glutamate receptor channel blockers on the development of pentylenetetrazol kindling in mice. Neurosci Behav Physiol 2007;37:75-81
   Google Scholar
• Wojtal K, Borowicz KK, Blaszczyk B, Czuczwar SJ. Interactions of excitatory amino acid receptor antagonists with antiepileptic drugs in three basic models of experimental epilepsy. Pharmacol Rep 2006;58:587-98
   Google Scholar
• Borowicz KK, Gasior M, Kleinrok Z, Czuczwar SJ. The non-competitive AMPA/kainate receptor antagonist, GYKI 52466, potentiates the anticonvulsant activity of conventional antiepileptics. Eur J Pharmacol 1995;281:319-26
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Duda AM, Kleinrok Z, Czuczwar SJ. Interaction of GYKI 52466, a selective non-competitive antagonist of AMPA/kainate receptors, with conventional antiepileptic drugs in amygdala-kindled seizures in rats. Pol J Pharmacol 2001;53:101-8
   Google Scholar
• Czuczwar SJ, Gasior M, Kaminski R, et al. GYKI 52466 [1-(4-aminophenyl)-4-methoxy-7,8-methylenedioxy-5H-2,3-benzodiazepine hydrochloride] and the anticonvulsive activity of conventional antiepileptics against pentetrazol in mice. Mol Chem Neuropathol 1998;33:149-62
   PubMedGoogle Scholar
• Borowicz KK, Kleinrok Z, Czuczwar SJ. The AMPA/kainate receptor antagonist, LY 300164, increases the anticonvulsant effects of diazepam. Naunyn Schmiedebergs Arch Pharmacol 2000;361:629-35
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Luszczki J, Szadkowski M, et al. Influence of LY 300164, an antagonist of AMPA/kainate receptors, on the anticonvulsant activity of clonazepam. Eur J Pharmacol 1999;380:67-72
   PubMed Web of Science ®Google Scholar
• Borowicz KK, Kleinrok Z, Czuczwar SJ. Glutamate receptor antagonists differentially affect the protective activity of conventional antiepileptics against amygdala-kindled seizures in rats. Eur Neuropsychopharmacol 2001;11:61-8
   Google Scholar
• Borowicz KK, Swiader M, Luszczki J, Czuczwar SJ. Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis. Epilepsia 2002;43:956-63
   PubMed Web of Science ®Google Scholar
• Zarnowski T, Kleinrok Z, Turski WA, Czuczwar SJ. 2,3-dihydroxy-6-nitro-7-sulfamoylbenzo(F)quinoxaline enhances the protective activity of common antiepileptic drugs against maximal electroshock-induced seizures in mice. Neuropharmacology 1993;32:895-900
   PubMed Web of Science ®Google Scholar
• Jonker DM, Voskuyl RA, Danhof M. Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments? Epilepsia 2007;48:412-34
   PubMed Web of Science ®Google Scholar
• Rogawski MA, Donevan SD. AMPA receptors in epilepsy and as targets for antiepileptic drugs. Adv Neurol 1999;79:947-63
   PubMedGoogle Scholar
• Smith M, Wilcox KS, White HS. Discovery of antiepileptic drugs. Neurotherapeutics 2007;4:12-17
   PubMed Web of Science ®Google Scholar
• De Sarro G, Paola ED, Gratteri S, et al. Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice. Pharmacol Res 2012;65:285-96
   Google Scholar
• Russo E, Donato di Paola E, Gareri P, et al. Pharmacodynamic potentiation of antiepileptic drugs' effects by some HMG-CoA reductase inhibitors against audiogenic seizures in DBA/2 mice. Pharmacol Res 2013;70:1-12
   PubMedGoogle Scholar
• Meldrum B. Do preclinical seizure models preselect certain adverse effects of antiepileptic drugs. Epilepsy Res 2002;50:33-40
   Google Scholar
• Donato Di Paola E, Gareri P, Davoli A, et al. Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice. Epilepsy Res 2007;75:112-21
   PubMed Web of Science ®Google Scholar
• Citraro R, Scicchitano F, De Fazio S, et al. Preclinical activity profile of alpha-lactoalbumin, a whey protein rich in tryptophan, in rodent models of seizures and epilepsy. Epilepsy Res 2011;95:60-9
   Google Scholar
• Franco V, Crema F, Iudice A, et al. Novel treatment options for epilepsy: focus on perampanel. Pharmacol Res 2013;70:35-40
   PubMed Web of Science ®Google Scholar